Search Results 801-810 of 18399 for Lactation

  1. Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy - Mayo Clinic

    Female subjects who are lactating or have a positive pregnancy test. Females of reproductive potential not willing or able to employ effective methods of ...

  2. A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer - Mayo Clinic

    Pregnancy, lactation, or inadequate contraception. Women must be post-menopausal infertile, or use a reliable means of contraception. Women of childbearing ...

  3. Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma - Mayo Clinic

    Female patients who are breastfeeding are not eligible; female patients who are lactating must agree to stop breastfeeding to participate in this study ...

  4. Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery - Mayo Clinic

    Lactating females unless they have agreed not to breastfeed their infants during treatment and for a period of 1 month following completion of treatment ...

  5. Lp-PLA2 and Coronary Atherosclerosis in Humans - Mayo Clinic

    pregnancy or lactation (women of child-bearing age will have a pregnancy test prior to angiogram); mental instability; federal medical center inmates ...

  6. Study of Efficacy and Safety of CTL019 in Adult ALL Patients - Mayo Clinic

    Participation eligibility · Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination ...

  7. A Study to Determine the Effectiveness and Safety of Oral Edaravone Administered in Subjects with Amyotrophic Lateral Sclerosis - Mayo Clinic

    Subjects who are female and pregnant (a positive pregnancy test) or lactating at the screening visit (Visit 1). Subjects of childbearing potential unwilling ...

  8. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    Pregnancy or lactation. Lack of peripheral venous access. Hospitalization (other than for elective reasons) within 4 weeks prior to randomization. Inability ...

  9. A Study in Second Line Metastatic Colorectal Cancer - Mayo Clinic

    ... lactating; History of inflammatory bowel disease or Crohn's disease requiring medical intervention (immunomodulatory or immunosuppressive medications or ...

  10. The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    be non-pregnant and non-lactating;; be either postmenopausal (defined as amenorrhea for ≥ 12 months and, if confirmation is necessary based on Investigator ...